Serum gamma-glutamyl transferase level is associated with the risk of pancreatic cystic neoplasms: A nationwide retrospective cohort study

Table 2 Multivariate regression analysis of the risk of pancreatic cystic neoplasm according to quartile

GGT	n	PCN	Duration, years	IR, per 1000 person-years	HR (95%CI)
					Model 11	Model 22	Model 33
Q1	678027	6864	6792685.48	1.01	1 (reference)	1 (reference)	1 (reference)
Q2	631006	6736	6330561.72	1.06	1.053 (1.018-1.089)	1.043 (1.009-1.079)	1.04 (1.005-1.075)
Q3	683678	7649	6860249.12	1.11	1.103 (1.068-1.14)	1.077 (1.043-1.113)	1.065 (1.03-1.102)
Q4	662954	7691	6585301.18	1.17	1.158 (1.121-1.197)	1.148 (1.111-1.185)	1.109 (1.07-1.15)

¹Model 1, not adjusted.

²Model 2, adjusted for age and sex.

³Model 3, adjusted for age, sex, income, body mass index, smoking, drinking, regular exercise, diabetes mellitus, hypertension, dyslipidemia, chronic kidney disease, aspartate aminotransferase, and alanine aminotransferase.

GGT: Gamma-glutamyl transferase; PCN: Pancreatic cystic neoplasm; IR: Incidence rate; HR: Hazard ratio; CI: Confidence interval.